Seth Lederman has bought TNXP on 9 days since Nov 2016

Seth Lederman is a physician, scientist, and entrepreneur who serves as Co‑Founder, Chief Executive Officer, and Chairman of Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP), a clinical‑stage biopharmaceutical company focused on developing therapies for central nervous system disorders and other conditions.( A trained immunologist and rheumatologist, he has led Tonix since founding it, guiding its pipeline of novel treatments, including candidates in pain management and neurological and infectious diseases.( Lederman has also been identified as an American physician associated with Tonix Pharmaceuticals, described as a specialty pharmaceutical product development company.(

Before founding Tonix, Lederman founded Targent Pharmaceuticals, which developed late‑stage oncology drugs, including a pure‑isomer levofolinic acid (levoleucovorin) product.( He is widely described in industry profiles and conference biographies as a physician‑scientist who has built and led multiple innovative biopharmaceutical companies, combining clinical and scientific expertise with executive leadership.(

Written by Perplexity from public sources.